Search research articles
Contact Us
Filters
Showing results (61-70 of 148) with videos related to
Page
of 15
Sort By:
British Journal of Cancer
|
October 28, 2010
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials
S-E Al-Batran, M Güntner, C Pauligk, et al.
Anticancer Research
|
November 11, 2006
Study participation improves treatment strategies and individual patient care in participating centers
W Janni, M Kiechle, H Sommer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2015
Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy
K Blackwell, V Semiglazov, D Krasnozhon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2011
Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival
J Dorn, V Magdolen, A Gkazepis, et al.
Breast Cancer Research and Treatment
|
December 9, 2015
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer
Thomas Kolben, D Augustin, R Armbrust, et al.
FEBS Letters
|
November 20, 1998
Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function
K Fischer, V Lutz, O Wilhelm, et al.
Investigational New Drugs
|
August 13, 2008
Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)
G Schilling, M Bruweleit, N Harbeck, et al.
Histopathology
|
June 27, 2007
Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue
K Lindemann, J Resau, J Nährig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy
P Hadji, C Jackisch, W Bolten, et al.
International Journal of Oncology
|
September 24, 1999
CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopy
F Noack, D Helmecke, R Rosenberg, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 148) with videos related to
Sort By:
Page
of 15
British Journal of Cancer
|
October 28, 2010
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials
S-E Al-Batran, M Güntner, C Pauligk, et al.
Anticancer Research
|
November 11, 2006
Study participation improves treatment strategies and individual patient care in participating centers
W Janni, M Kiechle, H Sommer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2015
Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy
K Blackwell, V Semiglazov, D Krasnozhon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2011
Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival
J Dorn, V Magdolen, A Gkazepis, et al.
Breast Cancer Research and Treatment
|
December 9, 2015
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer
Thomas Kolben, D Augustin, R Armbrust, et al.
FEBS Letters
|
November 20, 1998
Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function
K Fischer, V Lutz, O Wilhelm, et al.
Investigational New Drugs
|
August 13, 2008
Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)
G Schilling, M Bruweleit, N Harbeck, et al.
Histopathology
|
June 27, 2007
Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue
K Lindemann, J Resau, J Nährig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy
P Hadji, C Jackisch, W Bolten, et al.
International Journal of Oncology
|
September 24, 1999
CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopy
F Noack, D Helmecke, R Rosenberg, et al.
Page
of 15